Oncology with ImpediMed SOZO

Enhance Survivorship and Maximize Patient Health

Understanding fluid shifts that occur in the body can help in the early detection, management, and monitoring of chronic diseases. Lymphedema, most frequently caused by cancer or cancer treatments such as surgery, radiation, and chemotherapy, is one of the most feared consequences of cancer treatment among survivors. If left untreated it can become a lifelong condition.

Proactive Care

Obtaining a baseline L-Dex® score and body composition measurements upon cancer diagnosis is important to detecting lymphedema and enhancing cancer survivorship.

Precision Data

Utilizing the SOZO® Digital Health Platform in your clinical practice can greatly improve the quality of life for cancer patients and survivors.

oncology patient health
hf dex heart failure


ImpediMed SOZO – Objective Measure of Fluid Volume

Heart failure (HF), also known as congestive heart failure or chronic heart failure (CHF), affects ~26 million people globally. Current monitoring technologies such as weight scales or implantable pulmonary artery pressure (PAP) monitors are either inaccurate or require invasive procedures.

The SOZO® Digital Health Platform with HF-Dex™ offers a fast, accurate, and non-invasive measurement of fluid burden to better monitor and manage heart failure patients at the point-of-care.

Be a part of technology innovation with ImpediMed’s Heart Failure Early Adopter Program.

Rehabilitation and Therapy

Motivate Patient Compliance and Improve Outcomes with ImpediMed SOZO

Tracking changes in body composition – fluid, muscle, or fat – provides clinicians insight into disease progression and the ability to optimize treatment plans for success. Actionable data can also motivate patient compliance. Utilizing the SOZO® Digital Health Platform in your clinical practice can greatly improve outcomes and the quality of life for patients.¹

Precise Data

Tape measurements are rudimentary and unreliable and cannot distinguish between fluid and tissue gain. SOZO measures and tracks critical patient data.

Actionable Results

Detecting changes in body composition ensures your patients are losing or gaining weight the right way and helps establish healthy targets.

body composition with impedimed
impedimed bioimpedance


The Bioimpedance Research Technology of Choice

ImpediMed’s bioimpedance spectroscopy devices have been the bioimpedance research technology of choice for nearly three decades. The ability to instantly access raw impedance data over a broad range of 256 frequencies provides a wealth of additional information for researchers. Data such as characteristic frequency, characteristic impedance and cell membrane capacitance are not available from any other bioimpedance technology.


  1. Ridner SH, et al. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention. Lymphatic Research and Biology 2022.
  2. NIH, National Cancer Institute: https://cancercontrol.cancer.gov/ocs/statistics/statistics.html accessed April 30, 2019.
  3. Shaitelman SF, et al. Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin 2015;65:55-81.
  4. Ward, L. Is BIS ready for prime time as the gold standard measure. Jrn Lymphoedema 2009;4(2)